Publications
Postoperative cognitive dysfunction: an acute approach for the development of novel treatments for neuroinflammation
Here we discuss the use of postoperative cognitive decline (POCD), which is hypothesised to have a neuroinflammatory basis, as an acute indication to demonstrate the efficacy of novel neuroinflammatory drugs.
Latent inhibition and its potential as a biomarker for schizophrenia
Here we provide a brief review of the history behind latent inhibition and the limitations of existing human paradigms, before discussing a more recent latent inhibition task modification and its potential as a biomarker for schizophrenia.
Measuring functional outcomes in schizophrenia in an increasingly digital world
This review aims to give an overview of the different types of functional assessments commonly used in clinical trials and research involving patients with schizophrenia and highlight pertinent challenges surrounding the use of these as reliable, sensitive, and specific assessments in intervention trials.
Contact Us
We believe that neuroscience will be in the next decade what oncology has been in the last.